Abstract S5-07: SWOG S0500 – A randomized phase III trial to test the strategy of changing therapy versus maintaining therapy for metastatic breast cancer patients who have elevated circulating tumor cell (CTC) levels at first follow-up assessment

2013 ◽  
Author(s):  
JB Smerage ◽  
WE Barlow ◽  
DF Hayes ◽  
EP Winer ◽  
B Leyland-Jones ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Tumor Cell ◽  
Cancer Patients ◽  
Metastatic Breast ◽  
Circulating Tumor Cell ◽  
Phase Iii ◽  
Breast Cancer Patients ◽  
Phase Iii Trial

scholarly journals Establishment and Validation of Circulating Tumor Cell–Based Prognostic Nomograms in First-Line Metastatic Breast Cancer Patients

2013 ◽  
Vol 19 (6) ◽  
pp. 1596-1602 ◽  
Author(s):  
Antonio Giordano ◽  
Brian L. Egleston ◽  
David Hajage ◽  
Joseph Bland ◽  
Gabriel N. Hortobagyi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Tumor Cell ◽  
Cancer Patients ◽  
Metastatic Breast ◽  
Circulating Tumor Cell ◽  
Breast Cancer Patients ◽  
First Line

scholarly journals Comparative performance of different methods for circulating tumor cell enrichment in metastatic breast cancer patients

PLoS ONE ◽  
2020 ◽  
Vol 15 (8) ◽  
pp. e0237308
Author(s):  
Arik Drucker ◽  
Evelyn M. Teh ◽  
Ripsik Kostyleva ◽  
Daniel Rayson ◽  
Susan Douglas ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Tumor Cell ◽  
Cancer Patients ◽  
Metastatic Breast ◽  
Circulating Tumor Cell ◽  
Breast Cancer Patients ◽  
Comparative Performance ◽  
Cell Enrichment
Sign in / Sign up

Export Citation Format

Share Document